8/4/2022 12:28:22 PM - Trading in a wide intra-day range today perched near its 52-week high while little resistance remains due to overhead supply up to the $31 level. Quarterly earnings increases through Jun &#39;22 were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY &#39;21.<br><hr>7/27/2022 12:28:55 PM - Hitting a new 52-week high with today&#39;s gap up and volume-driven gain and little resistance remains due to overhead supply. Quarterly earnings increases through Mar &#39;22 were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY &#39;21.<br><hr>7/6/2022 12:10:07 PM - Hitting a new 52-week high with today&#39;s gain and little resistance remains due to overhead supply. Quarterly earnings increases through Mar &#39;22 were not strong and steady above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY &#39;21.<br><hr>3/31/2022 12:52:01 PM - Retreating from its 52-week high toward its 50 DMA line. Reported strong Sep and Dec &#39;21 quarterly earnings but prior quarterly earnings increases were not above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) had a downturn in FY &#39;21.<br><hr>11/23/2020 12:26:45 PM - Reversed after hitting another new 52-week high today following 3 considerable volume-driven gains. Found support near its 50 DMA line. Reported Sep &#39;20 quarterly earnings -23% on +6% sales revenues versus the year ago period, raising fundamental concerns. Prior quarterly earnings increases were above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) has been strong.<br><hr>11/20/2020 12:40:17 PM - Touched another new 52-week high today following 2 considerable volume-driven gains. Found support near its 50 DMA line. Reported Sep &#39;20 quarterly earnings -23% on +6% sales revenues versus the year ago period, raising fundamental concerns. Prior quarterly earnings increases were above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) has been strong.<br><hr>11/19/2020 12:42:22 PM - Touched a new 52-week high today with a gap and 2nd considerable volume-driven gain. Found support near its 50 DMA line. Reported Sep &#39;20 quarterly earnings -23% on +6% sales revenues versus the year ago period, raising fundamental concerns. Prior quarterly earnings increases were above the +25% minimum guideline (C criteria). Annual earnings history (A criteria) has been strong.<br><hr>6/24/2020 12:23:03 PM - Retreating for a 2nd consecutive loss after hitting a new 52-week high with a considerable volume-driven gain on when noted with caution in the 6/22/20 mid-day report - <i>&quot;Volume was above average during a recent handle-like consolidation, indicative of distributional pressure. Prior highs in the $17-19 area in recent years have acted as stubborn resistance after a long and choppy consolidation. Quarterly comparisons through Mar &#39;20 have been above the +25% minimum guideline (C criteria) versus the year ago period. Annual earnings history (A criteria) has been strong.&quot;</i><br><hr>6/23/2020 12:48:56 PM - Retreating today after hitting a new 52-week high with a considerable volume-driven gain on the prior session when noted with caution in the mid-day report - <i>&quot;Volume was above average during a recent handle-like consolidation, indicative of distributional pressure. Prior highs in the $17-19 area in recent years have acted as stubborn resistance after a long and choppy consolidation. Quarterly comparisons through Mar &#39;20 have been above the +25% minimum guideline (C criteria) versus the year ago period. Annual earnings history (A criteria) has been strong.&quot;</i><br><hr>6/22/2020 12:30:06 PM - Gapped up today hitting a new 52-week high with a considerable volume-driven gain. Volume was above average during a recent handle-like consolidation, indicative of distributional pressure. Prior highs in the $17-19 area in recent years have acted as stubborn resistance after a long and choppy consolidation. Quarterly comparisons through Mar &#39;20 have been above the +25% minimum guideline (C criteria) versus the year ago period. Annual earnings history (A criteria) has been strong.<br><hr>6/11/2020 12:12:55 PM - Prior highs in the $17-19 area acted as stubborn resistance after a long and choppy consolidation. Quarterly comparisons through Mar &#39;20 have been above the +25% minimum guideline (C criteria) versus the year ago period. Annual earnings history (A criteria) has been strong.<br><hr>5/22/2020 12:33:32 PM - Rebounding toward prior highs in the $17-19 area after a long and choppy consolidation. Quarterly comparisons through Mar &#39;20 have been above the +25% minimum guideline (C criteria) versus the year ago period. Annual earnings history (A criteria) has been strong.<br><hr>1/18/2018 12:36:39 PM - Up considerably today after a considerable volume-driven gain on the prior session, quickly getting extended from prior highs in the $19-20 area. Patient investors may watch for a pullback or secondary buy point to possibly develop and be noted. Disciplined investors avoid chasing stocks extended more than +5% above prior highs. Tallied a gain with above average volume on 1/09/18 but mostly wedged higher without great volume conviction since last noted in the 12/28/17 mid-day report - <i>&quot;Sales revenues growth rate has shown sequential acceleration with quarterly earnings increases through Sep &#39;17 very strong, well above the +25% minimum guideline. After years of losses it had profitable years FY &#39;15 and &#39;16.&quot;</i><br><hr>12/28/2017 11:57:49 AM - Still faces resistance up to the $20 level. Consolidating near its 50 DMA line ($17.80) after 4 consecutive gains marked by higher volume. Prior mid-day reports noted - <i>&quot;Sales revenues growth rate has shown sequential acceleration with quarterly earnings increases through Sep &#39;17 very strong, well above the +25% minimum guideline. After years of losses it had profitable years FY &#39;15 and &#39;16.&quot;</i><br><hr>12/26/2017 12:44:27 PM - Still faces resistance up to the $20 level while rebounding above its 50 DMA line ($17.84) with today&#39;s 4th consecutive gain marked by higher volume. Sales revenues growth rate has shown sequential acceleration with quarterly earnings increases through Sep &#39;17 very strong, well above the +25% minimum guideline. After years of losses it had profitable years FY &#39;15 and &#39;16.<br><hr>12/22/2017 12:26:14 PM - Gapped up on the prior session trading near its 50 DMA line when the mid-day report cautioned - <i>&quot;It faces resistance up to the $20 level while rebounding toward its 52-week high. Sales revenues growth rate has shown sequential acceleration with quarterly earnings increases through Sep &#39;17 very strong, well above the +25% minimum guideline. After years of losses it had profitable years FY &#39;15 and &#39;16.&quot;</i><br><hr>12/21/2017 12:22:13 PM - Gapped up today trading near its 50 DMA line, yet it faces resistance up to the $20 level while rebounding toward its 52-week high. Sales revenues growth rate has shown sequential acceleration with quarterly earnings increases through Sep &#39;17 very strong, well above the +25% minimum guideline. After years of losses it had profitable years FY &#39;15 and &#39;16.<br><hr>4/17/2017 12:13:37 PM - Perched near its 52-week high. Quarterly earnings increases through Dec &#39;16 have been strong, but its annual earnings (A criteria) history is not a match with the fact-based investment system&#39;s guidelines.<br><hr>